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Abstract: The synthesis of hydroxy-trans-1,3-diaminocyclohexanes based 
on nitroso-Diels-Alder cycloaddition of (cyclohexadienyl) phthalimide is 
reported. 
Key words: cycloaddition - regioselectivity - amino alcohols - enantiomeric 
resolution 
Trihydroxy-1,3-diaminocyclohexanes [also known as 2-de-oxy-
streptamine (1), Figure 1] are present as key structural features in 
aminoglucoside antibiotics, such as kanamycin A (2), which bind to the 
bacterial 16S ribosomal RNA.1 While the majority of aminoglucoside 
antibiotics possess a cis-1,3-diaminocyclohexane subunit, certain 
‘designer’ analogues, containing a trans-1,3-diaminocyclohexane 
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subunit exhibit interesting differential binding to bacterial and human 
rRNA. For example, 3 binds ca. one order of magnitude more tightly to 
E. coli 16S rRNA (K d = 6 ± 0.5 µM) compared to human 18S rRNA (K 
d = 68 ± 6.9 µM).2 Additionally, 2,3,4-trihydroxycyclohexane-trans-1,5-
diamines (e.g., 4) have been prepared as sugar mimics,3 and 2-
hydroxycyclohexane-trans-1,5-diamines (e.g., 5) have been utilized as 
intermediates in the synthesis of CC chemokine receptor 2 
antagonists.4 We herein report the synthesis of a series of 
hydroxydiaminocyclohexanes from the readily available5 
tricarbonyl(cyclohexadienyl)iron(1+) cation. 
 
Figure 1  
We have recently reported the synthesis of racemic N-
(cyclohexa-2,4-dienyl)phthalimide [(±)-6] (Scheme  1) from the 
(cyclohexadienyl)Fe(CO)3+ cation.6 Cycloaddition of 6 with 
nitrosobenzene7 gave the 2-oxa-3-azaoxabicyclo[2.2.2]oct-5-ene (±)-
7. The structure of 7 was tentatively assigned on the basis of its ¹H 
NMR spectral data. Assignment of the signals for the diastereotopic 
methylene protons (H3 and H3′) was facilitated by the magnitude of 
their vicinal couplings to H2; the syn-coupling (ca. 0˚ dihedral angle) 
is larger than the anti-coupling (ca. 120˚ dihedral angle). The signal 
for H3′ appears upfield of the signal for H3. These relative chemical 
shifts are due to the anisotropic effect of the olefin functionality. This 
tentative assignment was eventually corroborated on the basis of 
single crystal X-ray diffraction analysis.8 
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Scheme 1  
Dihydroxylation of 7 gave a single diol (±)-8. The relative 
stereochemistry of 8 was tentatively based on the perception that 
reaction would occur on the face of the olefin opposite to the sterically 
bulky phthalimide group. This tentative assignment was eventually 
corroborated by further derivatization of 8 (vide infra). Reductive N-O 
bond cleavage of 8 with molybdenum hexacarbonyl9 gave a single 
allylic alcohol, (±)-9. Hydrogenation of 7 or 8 over Raney nickel gave 
(±)-10 or (±)-11, respectively, while dihydroxylation of 9 gave the 
triol (±)-12 (Scheme 2). The structural assignment for 10 was 
tentatively assigned based on the structure of 7; this tentative 
assignment was eventually corroborated by single crystal X-ray 
diffraction analysis.8 The structures for 11 and 12 were assigned on 
the basis of their ¹H NMR spectral data. In particular, the signal for 
H6ax of each appears as a doublet (J ~ 3-4 Hz) of triplets (J ~ 13 Hz), 
indicative that the C1 phthalimide and the C5 phenylamino 
substituents are trans. Similarly, the signal for H1 of each appears as a 
doublet of doublet of doublets (J ~ 4.5, 10.8, and 13 Hz) indicative 
that the C1 phthalimide and the C2 hydroxy groups are trans. The 
relative stereochemistry of the C2 and C3 hydroxy groups was 
assigned on the basis of the H2/H3 coupling (11, J = 2.6 Hz; 12, J = 
9.6 Hz). 
 
Scheme 2  
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The preparation of optically active bicyclooxazines has been 
accomplished by the addition of optically active nitroso acyls to achiral 
dienes10 and by the copper-catalyzed addition of achiral nitroso acyls 
to achiral dienes in the presence of a chiral ligand.11 More recently, 
Jana and Studer have demonstrated a catalytic, enantioselective, and 
regiodivergent addition of 2-nitrosopyridine to racemic 
cyclohexadienes.12 To explore the possibility of generating optically 
active oxazines, the reaction of (±)-6 with the nitroso acyl generated 
from (±)-mandelohydroxamic acid [(±)-13] was examined (Scheme  
3). This gave a mixture of three diastereomeric cycloadducts 14, 15, 
and 16 in a ratio of ca. 5:3:2 (76%). Fractional crystallization of the 
mixture from acetonitrile gave the racemic diastereomer (±)-14 (25% 
isolated yield), whose structure was unambiguously assigned on the 
basis of single crystal X-ray diffraction analysis (Figure  3). Similarly, 
reaction of (±)-6 with the nitroso acyl generated from (R)-13 gave an 
optically active mixture of diastereomers 14-16; fractional 
crystallization of this mixture gave pure (+)-14 (11%). 
 
Scheme 3 a Isolated yield of pure compound 
The mother liquors from the recrystallization of 14, 15, and 16 
could not be further purified by recrystallization or chromatography. In 
this case, acylation of the racemic mixture of 14-16 gave a mixture of 
racemic 17, 18, and 19; separation of this mixture by preparative TLC 
gave pure (±)-18, and a mixture of 17 and 19. The structures of 14-
19 were tentatively assigned as indicated on the basis of their ¹H NMR 
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spectral data. Notably, the chemical shifts for signals of the 2-oxa-3-
azabicyclo[2.2.2]octane core of acetate 17 are relatively similar to 
those for 14. Similarly, the chemical shifts for 15 or 16 are relatively 
similar to those of 18 or 19 respectively. The upfield chemical shift for 
H2 of 15 (δ = 4.36), relative to that for H2 of 14 or 16 (δ = 4.81 or 
4.68, respectively) is due to the anisotropic effect of the olefin 
functionality.  
 
Figure 2 ORTEP drawing of (±)-14 with crystallographic 
numbering. C22H18N2O5; orthorhombic, ABa2, Z = 8, a = 21.9065(4) Å, 
b = 28.3819(6) Å, c = 5.80740(10)Å, V = 3610.74(12) Å³; 30401 
reflections measured, 3175 unique (R int = 0.0252). The final wR ² was 
0.0701 (all data). CCDC 778912.  
The diastereoselectivity may be rationalized by consideration of 
the possible transition states leading to the products (Scheme 4). It 
has been proposed that the nitroso dienophile derived from 
mandelohydroxamic acid reacts primarily in a six-membered ring 
hydrogen-bonded conformer.10a Approach of the (R)-nitroso dienophile 
to the exo-face of (R)-6 (i.e., TS 1) does not involve any steric 
hindrance, while approach of the (R)-nitroso dienophile to the endo-
face of (R)-6 (i.e., TS 2) involves steric repulsion between H4 and the 
phenyl substituent and between the nitroso oxygen and the 
phthalimide substituent. Thus, TS 1 (leading to 14) should be greatly 
favored over TS 2. In comparison, approach of the (R)-nitroso 
dienophile to the exo-face of (S)-6 (i.e., TS 3) involves repulsion 
between the nitroso oxygen and the phthalimide substituent, while 
approach of the (R)-nitroso dienophile to the endo-face of (S)-6 (i.e., 
TS 4) involves steric repulsion between H4 and the phenyl substituent. 
Thus, the energies of TS 3 (leading to 15) and TS 4 (leading to 16) 
are more equally matched in energy. 
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Scheme 4  
Attempted reduction of bicyclic oxazine (±)-14 with hydrogen 
over Raney nickel gave an intractable mixture of unidentified products. 
In comparison, reduction using titanocene(III) chloride13 proceeded to 
afford (±)-20, which upon further catalytic hydrogenation gave the 
saturated diaminocyclohexane (±)-21 (Scheme 5). Similar processing 
of (+)-14 gave (-)-20 and (-)-21, respectively. The structural 
assignments for 20 and 21 are based on comparison of their ¹H NMR 
spectral data with that for the previously prepared 9 and 10, 
respectively.  
 
Scheme 5  
In summary, the cycloaddition of (cyclohexadienyl)phthalimide 
(±)-6 with nitrosobenzene proceeds in a diastereofacial- and 
regioselective fashion to afford bicyclic oxazine (±)-7. In contrast, 
reaction of (±)-6 with the optically active nitroso acyl derived from 
mandelohydroxamic acid gave a mixture of three cycloadducts; the 
structure of the major product 14 was confirmed by X-ray crystal 
structure. The oxazine 7 could be rapidly transformed into hydroxy-
trans-1,3-diaminocyclohexanes 10-12, while oxazines (+)-14 was 
transformed into the optically active hydroxy-trans-1,3-
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diaminocyclohexane (-)-21. The structural assignments are based on 
their NMR spectral data and confirmed by X-ray diffraction for 10. 
Elemental analyses were obtained from Midwest Microlabs, Ltd., 
Indianapolis, IN, and HRMS were obtained from the University of 
Nebraska Center for mass spectrometry. Anhyd CH2Cl2 and anhyd DMF 
were purchased from Aldrich Chemical Company. Reactions were 
performed in flame-dried glassware under an atmosphere of N2 unless 
otherwise noted. Compounds 6,6 (±)-13, and (R)-1310a were prepared 
by literature procedures.  
3-Phenyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-ene 
[(±)-7]  
To a solution of nitrosobenzene (220 mg, 2.04 mmol) in anhyd 
CH2Cl2 (8 mL), at r.t. under N2, was added in one portion solid 6 (230 
mg, 1.02 mmol). The mixture was stirred for 2 h and then 
concentrated under reduced pressure. The residue was purified by 
column chromatography (silica gel, hexane-EtOAc, 4:1) to afford (±)-
7 (224 mg, 67%) as a colorless solid; mp 148-151˚C. 
¹H NMR (400 MHz, CDCl3): δ = 2.59 (td, J = 3.6, 13.6 Hz, 1 H), 
2.81 (ddd, J = 3.2, 9.6, 13.2 Hz, 1 H), 4.63-4.67 (m, 1 H), 4.90 (td, J 
= 4.0, 9.6 Hz, 1 H), 5.01 (dt, J = 1.6, 5.2 Hz, 1 H), 6.38 (ddd, J = 
1.8, 6.4, 8.2 Hz, 1 H), 6.53 (ddd, J = 1.6, 5.6, 8.4, 1 H), 6.96 (t, J = 
7.6 Hz, 1 H), 7.03 (d, J = 7.6 Hz, 2 H), 7.24 (t, J = 7.6 Hz, 2 H), 7.70-
7.84 (m, 4 H). 
¹³C NMR (100 MHz, CDCl3): δ = 27.6, 48.2, 57.1, 69.4, 117.7, 
122.5, 123.3, 128.4, 128.7, 131.7, 132.6, 134.3, 151.8, 168.5. 
Anal. Calcd for C20H16N2O3: C, 72.28; H, 4.85; N, 8.43. Found: 
C, 72.11; H, 4.89; N, 8.46. 
3-Phenyl-7-phthalimido-2-oxa-3-zabicyclo[2.2.2]octane-5,6-
diol [(±)-8]  
A sample of 7 (70 mg, 0.21 mmol) in acetone was treated with 
catalytic OsO4 (in toluene) and NMO for 10 h at r.t. in a fashion similar 
to the typical procedure to give (±)-12. After the standard workup, 
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the residue was adsorbed onto silica gel using CH2Cl2. This purified by 
column chromatography (layered onto silica gel, hexane-EtOAc, 1:1) 
to give (±)-8 (63 mg, 81%) as a colorless solid; mp 183-186˚C. 
¹H NMR (400 MHz, CDCl3): δ = 2.29 (ddd, J = 4.8, 11.6, 14.4 
Hz, 1 H), 2.72 (ddd, J = 1.2, 7.6, 14.4 Hz, 1 H), 3.44 (d, J = 7.6 Hz, 
OH, 1 H), 3.71 (d, J = 10.0 Hz, OH, 1 H), 3.98-4.13 (m, 2 H), 4.34 (t, 
J = 7.6 Hz, 1 H), 4.58 (dt, J = 3.2, 9.2 Hz, 1 H), 4.88 (ddd, J = 4.0, 
8.0, 11.2 Hz, 1 H), 7.04 (t, J = 7.2 Hz, 1 H), 7.22 (d, J = 8.0 Hz, 2 H), 
7.24 (dd, J = 7.2, 8.8 Hz, 2 H), 7.73-7.86 (m, 4 H). 
¹³C NMR (100 MHz, CDCl3): δ = 19.7, 45.0, 59.5, 64.1, 66.0, 
76.6, 116.1, 122.8, 123.8, 129.4, 131.5, 134.7, 149.8, 168.6. 
Anal. Calcd for C20H18N2O5˙0.6 H2O: C, 63.69; H, 5.13. Found: 
C, 63.66; H, 4.93. 
N -[(1 S *,2 S *,5 S *)-2-Hydroxy-5-(phenylamino)cyclohex-3-
enyl]phthalimide [(±)-9]  
To a solution of 7 (200 mg, 0.600 mmol) in MeCN (8 mL) and 
H2O (0.7 mL) was added Mo(CO)6 (158 mg, 0.600 mmol). The mixture 
was heated at reflux for 1 h, and then concentrated under reduced 
pressure. Purification of the residue by column chromatography (silica 
gel, hexane-EtOAc, 1:1) gave (±)-9 (90 mg, 45%) as a pale yellow 
foamy solid; mp 73-75 ˚C. 
¹H NMR (400 MHz, CDCl3): δ = 2.05 (br d, J = 13.2 Hz, 1 H), 
2.77 (dt, J = 4.8, 13.2 Hz, 1 H), 4.23 (br s, 1 H), 4.39 (ddd, J = 3.4, 
9.8, 13.2 Hz, 1 H), 4.84 (dd, J = 1.4, 9.8 Hz, 1 H), 5.82-5.95 (m, 2 
H), 6.64 (d, J = 7.6 Hz, 2 H), 6.71 (d, J = 7.2 Hz, 1 H), 7.17 (dd, J = 
7.0, 8.6 Hz, 2 H), 7.65-7.80 (m, 4 H). 
¹³C NMR (100 MHz, CDCl3): δ = 29.9, 48.0, 51.2, 68.4, 113.3, 
117.9, 123.4, 128.4, 129.6, 131.9, 133.8, 134.2, 146.7, 169.0. 
HRMS (FAB): m/z [M+] calcd for C20H18N2O3: 334.1317; found: 
334.1321. 
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N -[(1 S *,2 S *,5 R *)-2-Hydroxy-5-(phenylamino)cyclohex-
yl]phthalimide [(±)-10]; Typical Procedure  
In a small hydrogenation vessel, was placed a solution of 7 (0.3 
g, 0.9 mmol) in MeOH (30 mL). A slurry of Raney Ni (0.5 mL, 50% in 
H2O) was added and the mixture was stirred under H2 (2.76 bar) for 4 
h. After releasing the excess H2 pressure, the mixture was filtered 
through Celite and the solvent evaporated under reduced pressure. 
The residue was dissolved in EtOAc, adsorbed onto silica gel and 
purified by column chromatography (silica gel, hexane-EtOAc, 1:1) to 
give (±)-10 (225 mg, 74%) as a light yellow solid; mp 180-183˚C. 
¹H NMR (300 MHz, CD3OD): δ = 1.74-2.05 (m, 5 H), 2.51 (dt, J 
= 3.6, 13.1 Hz, 1 H), 3.80 (br s, 1 H), 4.27-4.40 (m, 2 H), 6.59 (t, J = 
7.6 Hz, 1 H), 6.69 (d, J = 7.6 Hz, 2 H), 7.09 (t, J = 7.6 Hz, 2 H), 7.74-
7.83 (m, 4 H). 
¹³C NMR (100 MHz, CD3OD): δ = 29.4, 30.3, 33.4, 54.1, 70.3, 
114.6, 118.1, 124.1, 130.2, 133.5, 135.3, 149.2, 170.4; one signal 
obscured by solvent. 
Anal. Calcd for C20H20N2O3: C, 71.41; H, 5.99. Found: C, 71.50; 
H, 6.04. 
N -[(1 S *,2 R *,3 S *,4 S *,5 S *)-2,3,4-Trihydroxy-5-
(phenylamino)cyclohexyl]phthalimide [(±)-11]  
The reduction of 8 (0.160 g, 0.437 mmol) in MeOH (30 mL) with 
H2 (2.76 bar) catalyzed by Raney Ni (0.3 mL, 50% in H2O) was carried 
out in a fashion similar to the typical procedure for (±)-10. Purification 
of the crude product by column chromatography (silica gel, EtOAc) 
gave (±)-11 (91 mg, 57%) as a colorless solid; mp 233-235˚C. 
¹H NMR (400 MHz, CD3OD): δ = 2.03 (td, J = 3.8, 13.2 Hz, 1 
H), 2.31 (dt, J = 3.2, 13.2 Hz, 1 H), 3.84 (dd, J = 3.0, 4.3 Hz, 1 H), 
3.99-4.03 (m, 1 H), 4.21 (t, J = 2.6 Hz, 1 H), 4.34 (dd, J = 2.6, 10.8 
Hz, 1 H), 4.64 (ddd, J = 3.8, 10.8, 13.2 Hz, 1 H), 6.57 (t, J = 7.6 Hz, 
1 H), 6.62 (d, J = 8.0 Hz, 2 H), 7.08 (t, J = 7.6 Hz, 2 H), 7.75-7.83 
(m, 4 H). 
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¹³C NMR (100 MHz, CD3OD): δ = 30.1, 48.3, 54.9, 70.2, 70.7, 
76.4, 114.2, 117.9, 124.1, 130.3, 133.4, 135.4, 149.4, 170.3. 
HRMS (FAB): m/z [M + H]+ calcd for C20H21N2O5: 369.1450; 
found: 369.1448. 
N -[(1 S *,2 R *,3 R *,4 R *,5 S *)-2,3,4-Trihydroxy-5-
(phenylamino)cyclohexyl]phthalimide [(±)-12]; Typical 
Procedure  
To a solution of 9 (50 mg, 0.15 mmol) in acetone (0.8 mL) was 
added a solution of NMO (30.0 mg, 0.230 mmol) in H2O (0.3 mL) 
followed by a solution of OsO4 in toluene (0.1 mL, 10 mol%). The 
mixture was stirred for 15 h at r.t. and then Na2S2O4 (26 mg) was 
added and stirring was continued for a further 30 min. The mixture 
was concentrated and the residue purified by column chromatography 
(silica gel, hexane-EtOAc, 1:4) to give (±)-12 (18 mg, 33%) as a 
colorless solid; mp 253-255˚C. 
¹H NMR (300 MHz, CD3OD): δ = 1.78 (br d, J = 13.3 Hz, 1 H), 
3.00 (dt, J = 3.9, 13.3 Hz, 1 H), 3.70-3.78 (m and dd, J = 2.7, 9.3 Hz, 
2 H total), 4.11 (narrow t, J = 2.6 Hz, 1 H), 4.43 (ddd, J = 4.2, 10.8, 
13.2 Hz, 1 H), 4.55 (d, J = 9.6, 10.2 Hz, 1 H), 6.62 (t, J = 7.2 Hz, 1 
H), 6.72 (d, J = 8.4 Hz, 2 H), 7.11 (dd, J = 7.5, 8.4 Hz, 2 H), 7.76-
7.83 (m, 4 H). 
¹³C NMR (75 MHz, acetone-d 6): δ = 28.1, 51.6, 53.3, 69.9, 
71.9, 73.7, 113.6, 117.4, 123.7, 129.8, 132.7, 135.1, 148.6, 168.8. 
HRMS (FAB): m/z [M + H]+ calcd for C20H21N2O5: 369.1450; 
found: 369.1447. 
3-Mandeloyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-
enes 14-16; Typical Procedure  
To a rapidly stirring solution of (±)-6 (0.600 g, 2.67 mmol) and 
NaIO4 (0.683 g, 3.19 mmol) in CH2Cl2 (10 mL), DMF (10 mL), and H2O 
(5 mL) was added, over a period of 45 min, a solution of (±)-
mandelohydroxamic acid (0.441 g, 2.64 mmol) in DMF (10 mL). The 
mixture was stirred for an additional 3 h, then poured into H2O and 
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extracted several times with CH2Cl2. The combined extracts were 
washed with brine, dried (Na2SO4), and concentrated. The residue was 
purified by column chromatography (silica gel, hexanes-EtOAc, 1:1) to 
afford a colorless solid (0.795 g, 77%). Analysis of this product by ¹H 
NMR spectroscopy indicated it to be a mixture of 14, 15, and 16 
(5:3:2). Recrystallization (MeCN) of two batches of the above size 
gave (±)-14 (0.513 g, 25%). 
(±)-14  
Mp 160-162˚C.  
¹H NMR (300 MHz, CDCl3): δ = 2.49 (ddd, J = 2.7, 4.5, 13.5 Hz, 
1 H), 2.60 (ddd, J = 3.3, 9.0, 13.5 Hz, 1 H), 4.15 (d, J = 7.5 Hz, 1 H), 
4.73 (t, J = 3.9 Hz, 1 H), 4.81 (td, J = 4.5, 9.0 Hz, 1 H), 5.25-5.36 (m 
and d, J = 6.6 Hz, 2 H total), 5.79 (t, J = 6.6 Hz, 1 H), 6.57 (t, J = 6.6 
Hz, 1 H), 7.19-7.30 (m, 5 H), 7.65-7.80 (m, 4 H). 
¹³C NMR (75 MHz, CDCl3): δ = 26.6, 47.6, 48.6, 71.6, 71.8, 
123.5, 127.8, 128.08, 128.12, 128.2, 131.4, 134.47, 134.51, 137.5, 
168.1, 173.1. 
Anal. Calcd for C22H18N2O5: C, 67.69; H, 4.64. Found: C, 67.48; 
H, 4.65. 
(±)-15  
¹H NMR (partial, CDCl3): δ = 2.30-2.50 (m, 2 H), 4.36 (td, J = 
4.0, 8.4 Hz, 1 H), 4.97-5.03 (m, 1 H), 5.21 (d, J = 7.2 Hz, 1 H), 6.53 
(t, J = 6.8 Hz, 1 H), 6.88 (t, J = 6.8 Hz, 1 H). 
(±)-16  
¹H NMR (partial, CDCl3): δ = 4.75-4.80 (m, 1 H), 5.50-5.55 (m, 
1 H), 6.15 (t, J = 6.9 Hz, 1 H), 6.39 (t, J = 6.8 Hz, 1 H). 
X-ray Structural Analysis of (±)-14  
A crystal suitable for X-ray diffraction analysis was grown from 
MeCN. Formula: C22H18N2O5, orthorhombic, space group Aba2, 
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a = 21.9065(4), b = 28.3819(6), c = 5.80740(10) Å, V = 3610.74(12) 
Å³, Z = 8, d calcd = 1.436 mg/m³, u = 0.854 mm-¹, 3175 unique 
reflections, wR2 = 0.0701. 
(7 S )-3-[( R )-Mandeloyl]-7-phthalimido-2-oxa-3-
azabicyclo[2.2.2]oct-5-ene [(+)-14]  
Reaction of (±)-6 (0.300 g, 1.33 mmol) with the nitrosoacyl 
generated from (R)-mandelohydroxamic acid (0.212 g, 1.27 mmol) 
was carried out in a fashion similar to the typical procedure for 14-16 
using (±)-mandelohydroxamic acid. Purification of the residue by 
column chromatography (silica gel, hexanes-EtOAc, 1:1) gave a 
colorless solid (0.316 g, 62%). Recrystallization (MeCN) gave (+)-14 
(57 mg, 11%); mp 180-183˚C. 
[α]D20 +126.5 (c 0.429, CH2Cl2).  
The ¹H NMR spectrum of this product was identical to that of the 
racemic compound. 
Reaction of 3-Mandeloyl-7-phthalimido-2-oxa-3-
azabicyclo[2.2.2]oct-5-ene with Acetic Anhydride  
To a mixture of 14, 15, and 16 (80 mg, 0.20 mmol) in CH2Cl2 
(1 mL), at r.t. was added dropwise pyridine (0.10 mL, 1.0 mmol) 
followed by Ac2O (0.10 mL, 1.1 mmol). The mixture was stirred for 12 
h, diluted with CH2Cl2 and quenched with 1 M HCl. The mixture was 
extracted several times with CH2Cl2 and the combined extracts were 
washed with brine, dried (Na2SO4), and concentrated. Purification of 
the residue by preparative TLC (hexane-EtOAc = 7:3) gave (±)-18 (17 
mg, 19%) as a colorless oil, followed by a mixture of (±)-17 and (±)-
19 (ca. 8:3 ratio, 39 mg, 41%) as a colorless oil. 
(±)-18  
¹H NMR (400 MHz, CDCl3): δ = 2.16 (s, 3 H), 2.38-2.43 (m, 2 
H), 4.47-4.55 (m, 1 H), 5.00-5.05 (m, 1 H), 5.33-5.38 (br s, 1 H), 
6.13 (s, 1 H), 6.55 (br t, J = 6.8 Hz, 1 H), 6.89 (br t, J = 7.2 Hz, 1 H), 
7.39-7.55 (m, 5 H), 7.70-7.80 (m, 4 H). 
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¹³C NMR (75 MHz, CDCl3): δ = 20.9, 26.9, 47.3, 48.9, 72.2, 
73.7, 123.5, 128.4, 128.5, 128.9, 129.2, 131.5, 134.3, 134.5, 135.0, 
168.2, 170.7; one CO signal not observed. 
HRMS (ESI): m/z [M + Na]+ calcd for C24H20N2NaO6: 455.1219; 
found: 455.1216. 
(±)-17  
¹H NMR (partial, CDCl3): δ = 2.45 (br d, J = 12.8 Hz, 1 H), 2.67 
(ddd, J = 3.2, 9.8, 12.8 Hz, 1 H), 4.80-4.84 (br s, 1 H), 4.96 (dt, J = 
4.2, 9.2 Hz, 1 H), 5.28-5.33 (br s, 1 H), 5.94 (br t, J = 6.8 Hz, 1 H), 
6.24 (s, 1 H), 6.61 (br t, J = 6.8 Hz, 1 H). 
(±)-19  
¹H NMR (partial, CDCl3): δ = 2.31 (dd, J = 2.8, 14.0 Hz, 1 H), 
2.82 (ddd, J = 3.6, 9.6, 13.6 Hz, 1 H), 4.73-4.77 (br s, 1 H), 5.47-
5.51 (br s, 1 H), 6.38 (br t, J = 7.2 Hz, 1 H). 
(2 R *)-2-Hydroxy- N -[(1 R *,4 R *,5 R *)-4-hydroxy-5-
phthalimidocyclohex-2-enyl)-2-phenylacetamide [(±)-20]; 
Typical Procedure  
To titanocene dichloride (93 mg, 0.38 mmol) and activated zinc 
dust (50 mg, 0.75 mmol), under N2 at r.t. was added freshly distilled 
THF (1.2 mL). The mixture was stirred for 45 min during which time 
the solution changed in color from red to olive green. The green 
mixture was cooled to -30˚C and a solution of (±)-14 (60 mg, 0.15 
mmol) in MeOH (1.5 mL) was added. The mixture was stirred for 1 h 
with the temperature maintained between -15 to -30˚C. The mixture 
was warmed to r.t. and quenched with sat. aq NH4Cl (5 mL) and then 
filtered through filter-aid. The filtrate was extracted several times with 
EtOAc, and the combined extracts were washed with brine, dried 
(Na2SO4), and concentrated. Purification of the residue by column 
chromatography (silica gel, EtOAc) gave (±)-20 (40 mg, 66%) as a 
colorless solid; mp 223-225˚C.  
¹H NMR (400 MHz, CD3OD): δ = 1.75 (tdd, J = 1.6, 3.2, 14.0 
Hz, 1 H), 2.64 (dt, J = 4.8, 14.0 Hz, 1 H), 4.40 (ddd, J = 12.8, 9.4, 
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3.1 Hz, 1 H), 4.49-4.54 (m, 1 H), 4.98 (s, 1 H), 5.75-5.81 (m, 1 H), 
5.94 (br d, J = 10.0 Hz, 1 H), 7.24 (t, J = 7.6 Hz, 1 H), 7.31 (t, J = 
8.0 Hz, 2 H), 7.45 (d, J = 7.6 Hz, 1 H), 7.78-7.74 (m, 2 H), 7.84-7.81 
(m, 2 H); one signal obscured by solvent. 
¹³C NMR (100 MHz, CD3OD): δ = 32.4, 45.8, 52.1, 67.9, 75.8, 
124.2, 127.4, 128.4, 129.4, 129.7, 133.4, 135.6, 136.5, 141.8, 170.1, 
175.2. 
HRMS (ESI): m/z [M + Na]+ calcd for C22H20N2NaO5: 415.1270; 
found: 415.1274. 
(2 R )-2-Hydroxy- N -[(1 R ,4 R ,5 R )-4-hydroxy-5-
phthalimidocyclohex-2-enyl]-2-phenylacetamide [(-)-20]  
The titanium-mediated reduction of (+)-14 (50 mg, 0.13 mmol) 
was carried out in a fashion similar to the typical procedure for (±)-
20. Purification of the residue by column chromatography (silica gel, 
EtOAc) gave (-)-20 as a colorless solid; mp 193-195 ˚C. 
[α]D20 -106 (c 0.270, MeOH).  
The ¹H NMR spectrum of this product was identical to that of the 
racemic compound. 
(2 R *)-2-Hydroxy- N -[(1 S *,4 R *,5 R *)-4-hydroxy-5-
phthalimidocyclohexyl]-2-phenylacetamide [(±)-21]  
The reduction of (±)-20 (30 mg, 0.077 mmol) in MeOH (6 mL) 
with H2 (2.76 bar) catalyzed by 10% Pd/C (2.5 mg) was carried out in 
a fashion similar that for the typical procedure for (±)-10. The mixture 
was filtered through filter-aid and concentrated. Purification of the 
residue by column chromatography (EtOAc) gave (±)-21 (23 mg, 
76%) as a colorless solid; mp 150-152˚C. 
¹H NMR (300 MHz, CD3OD): δ = 2.05-1.50 (m, 6 H), 2.43 (dt, J 
= 3.0, 12.3 Hz, 1 H), 4.34-4.04 (m, 3 H), 5.03 (br s, 1 H), 7.51-7.23 
(m, 5 H), 7.84-7.71 (m, 4 H); one signal obscured by solvent. 
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¹³C NMR (75 MHz, CD3OD): δ = 29.0, 30.7, 33.3, 46.4, 54.1, 
69.7, 75.6, 124.1, 128.4, 129.4, 129.8, 133.4, 135.4, 141.8, 170.2, 
175.1. 
HRMS (ESI): m/z [M + Na]+ calcd for C24H22N2NaO5: 417.1426; 
found: 417.1422. 
(2 R )-2-Hydroxy- N -[(1 S ,4 R ,5 S )-4-hydroxy-5-
phthalimidocyclohex-1-yl)-2-phenylacetamide [(-)-21]  
The reduction of (-)-20 (25 mg, 0.064 mmol) was carried out in 
a fashion similar to that for (±)-20. Purification of the residue by 
column chromatography (silica gel, EtOAc) gave (-)-21 as a colorless 
oil. 
[α]D20 -84 (c 0.20, MeOH).  
The ¹H NMR spectrum of this product was identical to that of the 
racemic compound. 
Supporting Information for this article is available online: 
https://www.thieme-
connect.de/media/synthesis/201106/supmat/sup_m07110ss-10-
1055_s-0030-1258430.pdf  
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Synthesis of Hydroxy- and Polyhydroxy-Substituted 1,3-
Diaminocyclohexanes 
Anobick Sar, Sergey Lindeman, William A. Donaldson* 
Supporting Information 
 
ORTEP drawing of (±)-7 with crystallographic numbering. C20H16N2O3; 
monoclinic, C2/c, Z = 8, a = 25.6400(13) Å, b = 5.4993(3) Å, c = 
22.3486(12) Å, β = 99.259(3)°, V = 3110.1(3) Å3; 21439 reflections 
measured, 2775 unique (Rint = 0.0603). The final wR2 was 0.1064 (all 
data). CCDC 778910. 
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ORTEP drawing of (±)-10 with crystallographic numbering. 
C20H20N2O3; monoclinic, P21/c, Z = 4, a = 14.9286(4) Å, b = 
6.8883(2) Å, c = 16.4514(5) Å, β= 99.053(2)°, V = 1670.67(8) Å3; 
13354 reflections measured, 2920 unique (Rint = 0.0217). The final 
wR2 was 0.0969 (all data). CCDC 778911. 
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